CD38 is a key enzyme for the survival of mouse microglial BV2 cells

Biochemical and Biophysical Research Communications

Volumn 418, Issue 4, 2012, Pages 714-719

  Ma, Yingxin ^a   Jiang, Jingwen ^b   Wang, Lu ^a   Nie, Hui ^a   Xia, Weiliang ^a   Liu, Jianrong ^b   Ying, Weihai ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Caspase 3; CD38; Cell survival; Microglia cells

Indexed keywords

CASPASE 3; CD38 ANTIGEN; LIPOCORTIN 5; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; ENZYME INACTIVATION; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA INTERFERENCE;

ANIMALS; ANTIGENS, CD38; APOPTOSIS; CASPASE 3; CELL SURVIVAL; MEMBRANE GLYCOPROTEINS; MICE; MICROGLIA; RNA, SMALL INTERFERING;

EID: 84862815380     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.084     Document Type: Article

References (17)

1. W. Xia, J. Han, G. Huang, W. Ying, Inflammation in ischaemic brain injury: current advances and future perspectives. Clin. Exp. Pharmacol. Physiol. 37 253-258.
2. V.H. Perry, J.A. Nicoll, C. Holmes, Microglia in neurodegenerative disease. Nat. Rev. Neurol. 6 193-201.
3. Watanabe H., Abe H., Takeuchi S., Tanaka R. Protective effect of microglial conditioning medium on neuronal damage induced by glutamate. Neurosci. Lett. 2000, 289:53-56.
4. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 2007, 184:53-68.
5. Lai A.Y., Todd K.G. Microglia in cerebral ischemia: molecular actions and interactions. Can. J. Physiol. Pharmacol. 2006, 84:49-59.
6. Lee H.C. Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers. Annu. Rev. Pharmacol. Toxicol. 2001, 41:317-345.
7. Aksoy P., White T.A., Thompson M., Chini E.N. Regulation of intracellular levels of NAD: a novel role for CD38. Biochem. Biophys. Res. Commun. 2006, 345:1386-1392.
8. Aksoy P., Escande C., White T.A., Thompson M., Soares S., Benech J.C., Chini E.N. Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. Biochem. Biophys. Res. Commun. 2006, 349:353-359.
9. Mayo L., Jacob-Hirsch J., Amariglio N., Rechavi G., Moutin M.J., Lund F.E., Stein R. Dual role of CD38 in microglial activation and activation-induced cell death. J. Immunol. 2008, 181:92-103.
10. +/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid. Redox. Signal. 2008, 10:179-206.
11. Y. Ma, H. Chen, X. He, H. Nie, C. Sheng, Q. Wang, W. Xia, W. Ying, NAD+ Metabolism and NAD+-Dependent Enzymes: Promising Therapeutic Targets for Neurological Diseases. Curr. Drug. Targets. (2011) (Epub ahead of print).
12. Ying W. Deleterious network hypothesis of apoptosis. Med. Hypotheses 1998, 50:393-398.
13. Ying W., Han S.K., Miller J.W., Swanson R.A. Acidosis potentiates oxidative neuronal death by multiple mechanisms. J. Neurochem. 1999, 73:1549-1556.
14. Ma Y., Chen H., Xia W., Ying W. Oxidative stress and PARP activation mediate the NADH-induced decrease in glioma cell survival. IJPPP 2011, 3:21-28.
15. Chen J., Zhou Y., Mueller-Steiner S., Chen L.F., Kwon H., Yi S., Mucke L., Gan L. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J. Biol. Chem. 2005, 280:40364-40374.
16. C.U. Choe, K. Lardong, M. Gelderblom, P. Ludewig, F. Leypoldt, F. Koch-Nolte, C. Gerloff, T. Magnus, CD38 exacerbates focal cytokine production, postischemic inflammation and brain injury after focal cerebral ischemia. PLoS One 6 e19046.
17. Levy A., Bercovich-Kinori A., Alexandrovich A.G., Tsenter J., Trembovler V., Lund F.E., Shohami E., Stein R., Mayo L. CD38 facilitates recovery from traumatic brain injury. J. Neurotrauma. 2009, 26:1521-1533.